COVID19: First antiviral pill available through GHS

Merck’s anti-Covid oral pill Molnupiravir /Lagevrio 200mg is the first antiviral drug for COVID-19 available in Cyprus through the General Healthcare System. Following a recommendation by the European Medicine Agency (EMA), the

COVID19: EU assesses Pfizer pill

EMA has started evaluating an application for fast-tracking authorisation of Pfizer’s COVID-19 oral antiviral medicine Paxlovid. The application treats mild-to-moderate COVID‑19 in adult and adolescent patients (12 and older weighing at least

EMA reviews anti-COVID-19 pill for early use

The European Medicines Agency will begin reviewing data on game-changing antiviral pill molnupiravir, produced by US company MSD, against COVID-19, to support countries who want to use this medicine before receiving final